These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 16898617

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Physicochemical and pharmacological characteristic and clinical efficacy of an anti-irritable bowel syndrome agent, polycarbophil calcium (Polyful)].
    Iwanaga Y.
    Nihon Yakurigaku Zasshi; 2002 Mar; 119(3):185-90. PubMed ID: 11915521
    [Abstract] [Full Text] [Related]

  • 6. Calcium polycarbophil (Mitrolan).
    Med Lett Drugs Ther; 1981 May 29; 23(11):52. PubMed ID: 7015097
    [No Abstract] [Full Text] [Related]

  • 7. Laxative and anti-diarrheal activity of polycarbophil in mice and rats.
    Saito T, Mizutani F, Iwanaga Y, Morikawa K, Kato H.
    Jpn J Pharmacol; 2002 Jun 29; 89(2):133-41. PubMed ID: 12120755
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of current drug therapies in irritable bowel syndrome: what works and does not work.
    Schoenfeld P.
    Gastroenterol Clin North Am; 2005 Jun 29; 34(2):319-35, viii. PubMed ID: 15862938
    [Abstract] [Full Text] [Related]

  • 9. Options for patients with irritable bowel syndrome: contrasting traditional and novel serotonergic therapies.
    Johanson JF.
    Neurogastroenterol Motil; 2004 Dec 29; 16(6):701-11. PubMed ID: 15601419
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Calcium polycarbophil improves constipation in primary autonomic failure and multiple system atrophy subjects.
    Sakakibara R, Yamaguchi T, Uchiyama T, Yamamoto T, Ito T, Liu Z, Odaka T, Yamaguchi C, Hattori T.
    Mov Disord; 2007 Aug 15; 22(11):1672-3. PubMed ID: 17149723
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Irritable bowel syndrome].
    Musch A.
    Med Monatsschr Pharm; 2006 Oct 15; 29(10):378-9. PubMed ID: 17058897
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Treatment of irritable bowel syndrome.
    Trinkley KE, Nahata MC.
    J Clin Pharm Ther; 2011 Jun 15; 36(3):275-82. PubMed ID: 21545610
    [Abstract] [Full Text] [Related]

  • 16. Drugs for irritable bowel syndrome.
    Treat Guidel Med Lett; 2006 Mar 15; 4(43):11-6. PubMed ID: 16498305
    [No Abstract] [Full Text] [Related]

  • 17. [Calcium polycarbophil in clinical practice. The therapy of constipation].
    Pallotta N, Rubinetto MP, Zaccaro C, Gizzi G, Villani V, Barbara L.
    Minerva Gastroenterol Dietol; 1993 Dec 15; 39(4):175-8. PubMed ID: 8161616
    [Abstract] [Full Text] [Related]

  • 18. Pharmacology, toxicology, clinical efficacy, and adverse effects of calcium polycarbophil, an enteral hydrosorptive agent.
    Danhof IE.
    Pharmacotherapy; 1982 Dec 15; 2(1):18-28. PubMed ID: 6765389
    [Abstract] [Full Text] [Related]

  • 19. Emerging treatments in neurogastroenterology: eluxadoline - a new therapeutic option for diarrhea-predominant IBS.
    Lacy BE.
    Neurogastroenterol Motil; 2016 Jan 15; 28(1):26-35. PubMed ID: 26690872
    [Abstract] [Full Text] [Related]

  • 20. Comparison of total costs of administering calcium polycarbophil and psyllium mucilloid in an institutional setting.
    Mamtani R, Cimino JA, Cooperman JM, Kugel R.
    Clin Ther; 1990 Jan 15; 12(1):22-5. PubMed ID: 2109660
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.